PRDX4 is emerging as an important therapeutic target in numerous diseases, such as metabolic syndromes (33), idiopathic pulmonary fibrosis (IPF) (34), liver injury (35), amyloid-beta aggregate-induced neuronal apoptosis (36). The gene discussed is PRDX4; the disease is metabolic syndrome.